Want to join the conversation?
$GILD said it will present 32 presentations related to its approved medicines and investigational therapies for the treatment of chronic hepatitis C at The Liver Meeting in San Francisco. Data include results from studies of drugs Harvoni & Sovaldi that advance the understanding of the profiles of these drugs in several patient populations.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.